It's hard to imagine the Journal of the American Medical Association – JAMA – without its editor-in-chief, Cathy DeAngelis, who will be stepping down this July. Since 2000 Dr. DeAngelis, JAMA’s first woman editor, has steered the peer-reviewed publication in important new directions and successfully brought about greater scientific integrity across the medical research and publishing industry. Because of her efforts, in concert with other prominent journal editors, virtually all clinical trials in the US are now listed in a public registry, as a condition of publication. JAMA won’t consider industry-funded research unless the data have been independently vetted.
My note: Someone please ask her why they don't make the full text of public interest articles available at no cost to all readers.